dc.contributor.author | Guantai, Eric M. | |
dc.contributor.author | Ncokazi, kanyile | |
dc.contributor.author | Egan, Timonthy J. | |
dc.contributor.author | Gut, Jiri | |
dc.contributor.author | Rosenthal, Philip J. | |
dc.contributor.author | Smith, peter J. | |
dc.contributor.author | Chibale, Kelly | |
dc.date.accessioned | 2013-04-22T13:46:47Z | |
dc.date.available | 2013-04-22T13:46:47Z | |
dc.date.issued | 2010-12 | |
dc.identifier.uri | http://www.sciencedirect.com/science/article/pii/S0968089610009193 | |
dc.identifier.uri | http://erepository.uonbi.ac.ke:8080/xmlui/handle/123456789/16512 | |
dc.identifier.uri | http://www.ncbi.nlm.nih.gov/pubmed/21044845 | |
dc.description.abstract | A targeted series of chalcone and dienone hybrid compounds containing aminoquinoline and nucleoside templates was synthesized and evaluated for in vitro antimalarial activity. The Cu(I)-catalyzed cycloaddition of azides and terminal alkynes was applied as the hybridization strategy. Several chalcone-chloroquinoline hybrid compounds were found to be notably active, with compound 8b the most active, exhibiting submicromolar IC50 values against the D10, Dd2 and W2 strains of Plasmodium falciparum | en |
dc.language.iso | en | en |
dc.relation.ispartofseries | Vol.18, Issue 23, Pages 8243–8256 2010; | |
dc.title | Design, synthesis and in vitro antimalarial evaluation of triazole-linked chalcone and dienone hybrid compounds | en |
dc.type | Article | en |
local.publisher | Department of Medicine. College of Health Sciences. University of Nairobi | en |